找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies; Heide Schatten Book 2021 Springer Nature Switzerland AG 2021 tiss

[復(fù)制鏈接]
21#
發(fā)表于 2025-3-25 04:05:12 | 只看該作者
0065-2598 ian cancer research areas and include cell and molecular details that are important for the specific subtopics. Comprehensive and concise reviews are included of key topics in the field..978-3-030-73361-2978-3-030-73359-9Series ISSN 0065-2598 Series E-ISSN 2214-8019
22#
發(fā)表于 2025-3-25 08:56:09 | 只看該作者
Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression,opment of novel curative or management drugs for this disease. This chapter discusses the major elements of immune suppression in HGSOC from a biological viewpoint, mechanisms of overcoming resistance to therapies, and recent therapy aimed at improving patient care and survival.
23#
發(fā)表于 2025-3-25 14:11:07 | 只看該作者
Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges,arian cancer. We also summarize the current published work using single-cell sequencing in ovarian cancer..By utilizing this novel technique to characterize the gene expression of rare subpopulations, new targets and treatment pathways may be identified in ovarian cancer to change treatment paradigms.
24#
發(fā)表于 2025-3-25 17:19:14 | 只看該作者
25#
發(fā)表于 2025-3-25 20:32:26 | 只看該作者
26#
發(fā)表于 2025-3-26 03:20:56 | 只看該作者
27#
發(fā)表于 2025-3-26 07:58:53 | 只看該作者
Book 2021 focused on Cell and Molecular Biology of Ovarian Cancer. Both books include new exciting aspects of ovarian cancer research with chapters written by experts in their respective fields who contributed their unique expertise in specific ovarian cancer research areas and include cell and molecular det
28#
發(fā)表于 2025-3-26 09:15:56 | 只看該作者
29#
發(fā)表于 2025-3-26 13:54:00 | 只看該作者
Epithelial Ovarian Cancer and Cancer Stem Cells,tage and because of the high recurrence rates of the disease. Recurrent ovarian cancer is classified according to the time interval between the last platinum-based chemotherapy and the occurrence of recurrence, to platinum-sensitive and platinum-resistant. Many theories tried to explain development
30#
發(fā)表于 2025-3-26 19:50:02 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 11:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
京山县| 馆陶县| 南昌市| 夏津县| 石首市| 偏关县| 长白| 温泉县| 台安县| 高雄县| 宜兴市| 定西市| 余庆县| 含山县| 华阴市| 浮山县| 华坪县| 凤城市| 达孜县| 呼伦贝尔市| 龙口市| 斗六市| 仙居县| 玛曲县| 临沭县| 天水市| 浮梁县| 鹤山市| 剑河县| 文化| 宜兰县| 安义县| 泰来县| 高要市| 平塘县| 措美县| 乌什县| 台安县| 阜平县| 上饶市| 寿宁县|